APA (7th ed.) Citation

S, P., G, S., A, B., S, S., IB, V., U, W., . . . F, P. (2017). Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(29), 3347. https://doi.org/10.1200/JCO.2017.73.4293

Chicago Style (17th ed.) Citation

S, Pignata, et al. "Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 29 (2017): 3347. https://doi.org/10.1200/JCO.2017.73.4293.

MLA (9th ed.) Citation

S, Pignata, et al. "Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 35, no. 29, 2017, p. 3347, https://doi.org/10.1200/JCO.2017.73.4293.